Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP

American Journal of Clinical Pathology
Kamran Darabi, Anders H Berg

Abstract

Much of idiopathic thrombotic thrombocytopenic purpura (TTP) is attributed to the presence of an autoantibody to ADAMTS13, the metalloprotease that degrades ultralarge von Willebrand protein multimers. Most patients respond to treatment with therapeutic plasma exchange (TPE), which replaces the missing protease and removes the circulating inhibitor. However, a substantial fraction of idiopathic TTP cases (10%-20%) might not respond to TPE alone, and, therefore, interest has been gathering around the use of the novel immunosuppressive anti-B-cell antibody, rituximab. We report 2 cases of refractory TTP in which the combined use of plasma exchange and rituximab was associated with clinical resolution of active TTP, and we discuss the benefits and possible timing of combined therapy.

References

Sep 28, 2002·American Journal of Hematology·Jens ChemnitzDietmar Söhngen
Jan 17, 2003·Annals of Internal Medicine·Xinglong ZhengMorey A Blinder
Feb 18, 2003·British Journal of Haematology·Sarah L AllfordUNKNOWN Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology
Feb 28, 2003·European Journal of Haematology·Han-Mou Tsai, Keith Shulman
Oct 11, 2003·Transplant Immunology·Carsten SchröderRichard N Pierson
Mar 11, 2004·British Journal of Haematology·Roslyn YomtovianHan-Mou Tsai
Apr 22, 2004·Journal of Thrombosis and Haemostasis : JTH·S SallahN P Nguyen

❮ Previous
Next ❯

Citations

Mar 8, 2014·Advances in Chronic Kidney Disease·Ainslie M HildebrandWilliam F Clark
May 17, 2011·European Journal of Internal Medicine·Wilma Barcellini, Alberto Zanella
Mar 31, 2010·Seminars in Hematology·Roberto Stasi
Sep 25, 2009·Molecular Genetics and Metabolism·Priya S KishnaniY-T Chen
Dec 20, 2015·Hematology/oncology and Stem Cell Therapy·Sara KhodorChakra P Chaulagain
Nov 21, 2007·La Revue de médecine interne·N SchleinitzJ R Harlé
Aug 21, 2008·Journal of Clinical Apheresis·Sushama JastiBernard Poiesz
Mar 6, 2008·British Journal of Haematology·Bernadette Garvey
Feb 20, 2013·Journal of Clinical Apheresis·Rami B Ibrahim, Rasheed Abiodun Balogun
Feb 18, 2011·American Journal of Hematology·Daan DierickxDrew Provan
Feb 26, 2013·British Journal of Clinical Pharmacology·Florent PuissetJacques Pourrat
Jul 17, 2013·Journal of Clinical Apheresis·Jatinder GoyalMarisa B Marques
Aug 22, 2015·European Journal of Internal Medicine·Antoine FroissartUNKNOWN French Reference Center for Thrombotic Microangiopathies
Sep 16, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G-W SongE-Y Tak
Oct 30, 2007·Pharmacotherapy·Rami B IbrahimDavid J Edwards
Jan 27, 2011·The Journal of Clinical Investigation·Junmei ChenJosé A López

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.